On September 16, 2026, IDEXX Laboratories, Inc., a global leader in pet healthcare innovation, announced the acquisition of CoVetAI Inc. (CoVet), a leading and rapidly growing provider of AI-native ambient listening and clinical workflow software for veterinary practices. The financial terms of the transaction were not disclosed. Wilson Sonsini Goodrich & Rosati advised CoVet on the transaction.

CoVet helps veterinary teams automatically capture and organize information across the patient care journey, from consultation to treatment planning and client follow-up, reducing documentation burden and saving clinicians’ time. The acquisition expands the value of IDEXX’s software, diagnostics, and AI offerings by making information more accessible, actionable, and connected across the practice. CoVet will be integrated into the IDEXX software ecosystem, which will continue to support other ambient scribe solutions and third-party integrations. CoVet will also continue to integrate with non-IDEXX practice management systems.

The Wilson Sonsini team that advised CoVet on the transaction included:

Mergers & Acquisitions
Martin Korman
Remi Korenblit
Esther Lukman
Eleanor Bleecker
Cassie Wetzel
Daniel Cornell
Patrick Sun
Ketan Gupta

Technology Transactions
Barath Chari
Erica Hur

Data, Privacy, and Cybersecurity
Daniel Chen
Nikolaos Theodorakis
Dan Shin

Employee Benefits and Compensation
Matthew Norgard
Jason Chan
Laura Yun

Employment Law
Matt Gorman
Quinn Christie
Allie Zunski

Tax
Derek Wallace
Anjali Krishnan

Regulatory
Joshua Gruenspecht
Seth Cowell
Anne Seymour
Jack Davies
Nate Yang
Georgia Cooper-Dervan

Antitrust and Competition
Jamillia Ferris
Michelle Yost Hale
Deirdre Carroll
Kimberley Biagioli
Miata Eggerly
Andrew Morrison
Hedi Thlibi
Oliver Green

Real Estate
Susan Reinstra
Catherine Johnson
Alex Corluyan
Paige Baker

For more information, please see IDEXX’s news release.